SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

May 31, 2025

Accounting Policies [Abstract]

SCHEDULE OF NET INVENTORIES

The following is a summary of approximate net inventories:

	May 31,
	2025			2024
Raw materials	$	1,071,000		$	1,519,000
Work in progress		743,000			1,145,000
Finished products		147,000			179,000
Total gross inventory	$	1,961,000		$	2,843,000
Inventory reserve		(471,000	)		(467,000	)
Inventories, net	$	1,490,000		$	2,376,000

SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

In applying the Black-Scholes option-pricing model, the following assumptions used in the valuation of awards issued for years ended May 31, 2025 and 2024:

	For the year ended May 31,
	2025			2024
Dividend yield		0	%		0	%
Expected volatility		105.90 - 117.41	%		100.54 - 111.98	%
Risk free interest rate		3.68 - 4.52	%		4.00 - 4.59	%
Expected term		4.69 - 6.25 years			4.69 - 6.25 years

SCHEDULE OF DISAGGREGATION REVENUE

The following is a breakdown of revenues according to markets to which the products are sold:

	For Year Ended May 31,
	2025		2024
Clinical lab	$	3,181,000	$	3,236,000
Over-the-counter		1,049,000		1,426,000
Contract manufacturing		1,070,000		741,000
Physician’s office		11,000		12,000
Total	$	5,311,000	$	5,415,000

SCHEDULE OF SEGMENT REPORTING

The Company’s reportable segment product sales, net and net income (loss) for the years ended May 31, 2025 and 2024 consisted of the following :

	For the Year Ended May 31,
	2025			2024
Net sales	$	5,311,000		$	5,415,000
Cost of sales		(4,813,000	)		(4,804,000	)
Gross profit		498,000			611,000
Operating expenses:
Sales and marketing expense		1,628,000			2,339,000
General and administrative expense		2,984,000			3,148,000
Research and development expense		1,023,000			1,491,000
Total operating expense		5,635,000			6,978,000
Loss from operations		(5,137,000	)		(6,367,000	)
Other income:
Dividend and interest income		165,000			431,000
Total other income		165,000			431,000
Loss before income taxes		(4,972,000	)		(5,936,000	)
Provision for income taxes		(1,000	)		(42,000	)
Net loss	$	(4,973,000	)	$	(5,978,000	)